| Literature DB >> 25279277 |
Paul Keilah Lunga1, Jean de Dieu Tamokou2, Simeon Pc Fodouop2, Jules-Roger Kuiate2, Joseph Tchoumboue3, Donatien Gatsing2.
Abstract
Paullinia pinnata Linn (Sapindaceae) is a medicinal plant, locally used in the West Region of Cameroon for the treatment of typhoid fever. This work was designed to evaluate the antityphoid and antioxidant activities of the extracts and compounds of P. pinnata. The methanol extracts of the leaves and stems were tested for antityphoid and antioxidant activities. Compounds were isolated, and their structures elucidated by analysis of spectroscopic data in conjuction with literature data and tested for the same activities. The leaf extract was also tested in vivo for its antityphoid potential in a Salmonella typhimurium-induced typhoid fever model in Wistar rats. Seven known compounds: methylinositol (1), β-sitosterol (2), friedelin (3), 3β-(β-D-Glucopyranosyloxy)stigmast-5-ene (4), (3β)-3-O-(2'-Acetamido-2'-deoxy-β-D-glucopyranosyl) oleanolic acid (5), (3β,16α-hydroxy)-3-O-(2'-Acetamido-2'-deoxy-β-D-glucopyranosyl) echinocystic acid (6) and (3β,)-3-O-[β-D-glucopyranosyl-(1″-3')-2'-acetamido-2'-deoxy-β-D-galactopyranosyl]oleanolic acid (7) were isolated. Compounds 5 and 1 showed the highest antibacterial (MIC = 0.781-1.562 μg/ml) and DPPH radical scavenging (RSa50 = 19.27 ± 4.43 μg/ml) activities respectively. The maximum extract dose (446.00 mg/kg bw) had comparable activity with ciprofloxacin (7.14 mg/kg bw) and oxytetracycline (5 mg/kg bw). The extract induced significant dose-dependent increase of WBCs and lymphocytes. These results support the ethnomedicinal use of P. pinnata and its isolated Compounds could be useful in the standardization of antityphoid phytomedicine from it.Entities:
Keywords: Antityphoid; Methylinositol; Oleanane-type triterpenoids; Paullinia pinnata; Radical scavenging properties
Year: 2014 PMID: 25279277 PMCID: PMC4162521 DOI: 10.1186/2193-1801-3-302
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Figure 1Chemical structures of compounds from the leaves (1-3) and stems (4-7) of
Minimum inhibitory (MIC) and bactericidal (MBC) concentrations (μg/ml) of extracts and compounds from
| Test substance | Parameter (μg/ml) |
|
|
|
|
|---|---|---|---|---|---|
| Extracta | MIC | 781 | 48 | 781 | 781 |
| MBC | 781 | 390 | 3125 | 3125 | |
| MBC/MIC | 1 | 8 | 4 | 4 | |
| Extractb | MIC | 781 | 781 | 390 | 390 |
| MBC | 1562 | 1562 | 1562 | 3125 | |
| MBC/MIC | 2 | 2 | 4 | 8 | |
| 1 | MIC | 6.25 | 1.562 | 1.562 | 25 |
| MBC | 50 | 12.5 | 12.50 | 100 | |
| MBC/MIC | 8 | 8 | 8 | 4 | |
| 2 | MIC | 100 | 100 | 100 | 100 |
| MBC | / | / | / | / | |
| MBC/MIC | nd | nd | nd | nd | |
| 3 | MIC | 25 | 50 | 100 | 100 |
| MBC | 50 | 100 | 100 | / | |
| MBC/MIC | 2 | 2 | 1 | nd | |
| 4 | MIC | 50 | 25 | 12.5 | 25 |
| MBC | 100 | 100 | 50 | 50 | |
| MBC/MIC | 2 | 4 | 4 | 2 | |
| 5 | MIC | 1.562 | 1.562 | 0.781 | 0.781 |
| MBC | 1.562 | 1.562 | 1.562 | 0.781 | |
| MBC/MIC | 1 | 1 | 2 | 1 | |
| 6 | MIC | 25 | 25 | 12.50 | 12.5 |
| MBC | 25 | 50 | 50 | 25 | |
| MBC/MIC | 1 | 2 | 4 | 2 | |
| 7 | MIC | 25 | 50 | 3.125 | 12.5 |
| MBC | 50 | 100 | 6.250 | 12.5 | |
| MBC/MIC | 2 | 2 | 2 | 1 | |
| Ciprofloxacin | MIC | 0.195 | 0.195 | 1.562 | 0.781 |
| MBC | 0.781 | 0.781 | 1.562 | 3.125 | |
| MBC/MIC | 4 | 4 | 1 | 4 | |
| Gentamycin | MIC | 6.25 | 1.562 | 3.125 | 3.13 |
| MBC | 12.5 | 6.25 | 12.5 | 6.25 | |
| MBC/MIC | 2 | 4 | 4 | 2 |
Extracta: methanol extract of the leaves; Extractb: methanol extract of the stems; nd: not determined (greater than 100 μg/ml).
Figure 2Evolution of treatment of infected rats as a function of extract dose. CE: Crude extract.
Variation of hematological parameters of rats after treatment with methanol leaf extract
| Blood parameter | Dose (mg/Kg bw.) | |||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 55.75 | 111.5 | 223 | 446 | Cipro (7.14) | Oxy (5.00) | Ref | |
| Hematocrite (%) | 35.71 ± 4.71a | 37.78 ± 3.76a | 33.81 ± 6.240a | 39.22 ± 2.51a | 36.04 ± 1.27a | 37.59 ± 2.13a | 37.35 ± 2.44a | 38.36 ± 1.58a |
| RBC Count (106 mm−3) | 4.023 ± 0.096a | 4.016 ± 0.090a | 4.126 ± 0.138a | 4.030 ± 0.160a | 4.053 ± 0.070a | 4.210 ± 0.253a | 4.193 ± 0.209a | 4.333 ± 0.145a |
| WBC Count (103 mm−3) | 5.356 ± 0.741ab | 5.320 ± 0.534ab | 6.266 ± 0.862bc | 7.553 ± 0.642c | 6.606 ± 1.572bc | 5.833 ± 1.264bc | 4.040 ± 0.065a | 4.070 ± 0.075a |
| Lymphocytes (%) | 51.000 ± 4.582b | 51.000 ± 6.082b | 54.666 ± 4.163bc | 65.333 ± 7.094c | 65.333 ± 5.859c | 52.333 ± 3.785b | 45.000 ± 6.000b | 33.333 ± 4.509a |
| Monocytes (%) | 6.333 ± 0.577ab | 6.166 ± 0.577ab | 5.666 ± 0.763a | 7.667 ± 0.288ab | 6.500 ± 1.500ab | 8.000 ± 1.322b | 5.667 ± 1.154a | 6.833 ± 0.763ab |
| Eosinophils (%) | 0.667 ± 0.288a | 0.833 ± 0.288a | 1.000 ± 0.000a | 1.667 ± 0.288b | 0.667 ± 0.288a | 0.833 ± 0.288a | 0.833 ± 0.288a | 1.000 ± 0.000a |
| Basophils (%) | 0.833 ± 0.577a | 0.833 ± 0.288a | 1.000 ± 0.000a | 0.833 ± 0.288a | 0.833 ± 0.288a | 0.667 ± 0.577a | 0.833 ± 0.288a | 0.167 ± 0.288a |
| Neutrophils (%) | 37.500 ± 8.261a | 36.333 ± 1.892a | 35.667 ± 1.892a | 30.667 ± 1.607a | 35.167 ± 9.278a | 37.333 ± 5.299a | 40.833 ± 5.392a | 54.833 ± 1.154b |
Across each line, values with different letter superscripts are significantly different, at p < 0.05. (Waller Dunkan test). Ref: values from animals of group 1, that were not infected and received distilled water during treatment; Cipro: ciprofloxacin; Oxy: oxytetracycline.
DPPH radical scavenging activities of the extracts and compounds from leave and stems
| Test substance | RSa50 (μg/ml) | |
|---|---|---|
| Extracts | Extracta | 116.74 ± 4.20cd |
| Extractb | 99.61 ± 4.69c | |
| Compounds | 1 | 19.27 ± 4.43b |
| 2 | nd | |
| 3 | nd | |
| 4 | 247.30 ± 6.22f | |
| 5 | 4763.60 ± 38.26h | |
| 6 | 865.88 ± 26.84g | |
| 7 | 147.23 ± 5.71e | |
| Reference | Vitamin C | 5.31 ± 1.09a |
Extracta, leaf extract; Extractb, stem extract. Along each column, values with the same letter superscripts are not significantly different. Waller Dunkan (p < 0.05).; nd: not determined (RSa50 > 5000 μg/ml).